CLINICAL_TRIALS
trial_result
· 2023-12-11
Clinical Trial Update: A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD) [Phase 1, Phase 2]
Summary
A Phase 1/2 study of AR100DP1 in mild to moderate atopic dermatitis was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arjil Pharmaceuticals LLC | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-12-11